Management of antiviral drug resistance in chronic hepatitis B
about
Application of nucleoside analogues to liver transplant recipients with hepatitis BAntiviral drug resistance as an adaptive processCost-effectiveness analysis of lamivudine, telbivudine, and entecavir in treatment of chronic hepatitis B with adefovir dipivoxil resistance.On-treatment HBV DNA dynamics predict virological breakthrough in entecavir-treated HBeAg-positive chronic hepatitis BRemoval of Integrated Hepatitis B Virus DNA Using CRISPR-Cas9.Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-c]pyrimidines as Capsid Assembly Inhibitors for HBV Treatment.Capturing virus evolution by proteomic bioinformatics: Hunting for characteristic mutations in the hepatitis E virus genome.
P2860
Q26859796-28D23F54-9F66-4656-A7A6-7A2C97915388Q33878407-51B9D3DB-0B66-4C85-AC6A-04FAFADD4C92Q35694422-465677EF-19F1-4684-98F1-9450091998E3Q36325645-093EC077-0ED9-49EF-BE58-84F5F59A3956Q37714431-6E4C8C1B-A38F-4EEF-90F5-32109EAEF3F1Q41930281-CEE2E8F3-A17E-4D65-91E6-E1A0F0459661Q41930784-5B1A04CA-5A86-4601-AEED-8F35BD08F0C8
P2860
Management of antiviral drug resistance in chronic hepatitis B
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Management of antiviral drug resistance in chronic hepatitis B
@en
type
label
Management of antiviral drug resistance in chronic hepatitis B
@en
prefLabel
Management of antiviral drug resistance in chronic hepatitis B
@en
P2860
P1476
Management of antiviral drug resistance in chronic hepatitis B
@en
P2093
Hong Joo Kim
Ki Bae Bang
P2860
P304
11641-11649
P356
10.3748/WJG.V20.I33.11641
P407
P577
2014-09-01T00:00:00Z